Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
Arbutus Biopharma Corporation reports earnings inline with expectations. Reported EPS is $-0.12 EPS, expectations were $-0.12.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Whitefort Capital David Salanic | 13,197,062 | $32,992,655 | +11% | 21.03% |
2. | Two Seas Capital Sina Toussi | 9,041,927 | $22,604,818 | +10% | 5.51% |
3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 4,719,903 | $11,799,758 | 0.12% | |
4. | Hudson Bay Capital Management Sander Gerber | 4,139,904 | $10,349,760 | -1% | 0.06% |
5. | ADAR1 Capital Management Daniel Schneeberger | 3,468,824 | $8,672,060 | 3.09% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$6.95 | 1,000 | Director | 1,000 | 2015-08-24 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.31 | 4,358 | Officer | 125,542 | 2024-02-02 | Filing | |
$2.31 | 9,593 | Officer | 181,907 | 2024-02-02 | Filing | |
$2.31 | 9,982 | Officer | 1,485,121 | 2024-02-02 | Filing | |
$2.31 | 10,164 | Officer, Director | 1,504,793 | 2024-02-02 | Filing | |
$5.09 | 200,000 | Officer | 1,303,403 | 2021-12-01 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 10,390,300 | $25,975,752 | 0% | |
2. | 6,984,112 | $17,460,282 | 0% | |
3. | 5,988,883 | $14,972,208 | 0% | |
4. | 2,817,695 | $7,044,982 | 0% | |
5. | 2,396,760 | $5,991,900 | 0% |